Safety and Efficacy of Dexmedetomidine in Painless Colonoscopy
Status:
Unknown status
Trial end date:
2019-12-30
Target enrollment:
Participant gender:
Summary
50 patients who undergo painless colonoscopy from May 1, 2019 to December 30, 2019 will be
randomized to two groups: Propofol group: propofol is used as a sedative strategy;
Dexmedetomidine group: Dexmedetomidine as a sedative strategy. Compared of comfort and pain
score of patients, the occurrence of adverse events and the satisfaction score of
endoscopists between two groups. This study aims to investigate whether dexmedetomidine is
effectively and safely in Painless Colonoscopy, and improve the comfortable and safety of
Painless Colonoscopy.